Related Experiment Video
Updated: Mar 1, 2026

Author Spotlight: Advances in Brain Energy Metabolism Research Using the Drosophila Model
Published on: October 27, 2023
Endogenous Probes for Drug Transporters: Balancing Vision With Reality
A D Rodrigues1, K S Taskar2, H Kusuhara3
1Pharmacokinetics, Dynamics & Metabolism, Medicine Design, Pfizer Inc., Groton, Connecticut, USA.
Abstract:
Various endogenous probes have been identified for a number of hepatic and renal drug transporters and available clinical data indicate that they could be leveraged in phase I trials to facilitate subject phenotyping and drug-drug interaction (DDI) assessment. Despite the progress, however, it is recognized that the menu of probes needs expanding, that existing probes need further characterization and validation, and that compound files need to be built in support of probe absorption-metabolism-distribution-excretion-DDI modeling exercises.
Insights
Endogenous probes aid hepatic and renal drug transporter studies in early trials. Further characterization and validation are needed to expand their use in drug-drug interaction assessments.
Area of Science:
- Pharmacology
- Drug Metabolism
- Clinical Pharmacology
Background:
- Endogenous probes are identified for hepatic and renal drug transporters.
- Clinical data suggest their utility in Phase I trials for phenotyping and drug-drug interaction (DDI) assessment.
Purpose of the Study:
- To highlight the need for expanding the repertoire of endogenous probes.
- To emphasize the necessity of further characterization and validation of existing probes.
- To underscore the importance of building compound files for modeling.
Main Methods:
- Literature review of endogenous probes for drug transporters.
- Analysis of clinical data regarding probe application in Phase I trials.
- Identification of gaps in current probe characterization and validation.
Main Results:
- Existing endogenous probes show potential for subject phenotyping and DDI assessment.
- There is a recognized need to expand the available menu of probes.
- Further characterization and validation of current probes are required.
Conclusions:
- Expanding and validating endogenous probes is crucial for advancing drug transporter research.
- Enhanced probe utility will improve drug development through better phenotyping and DDI prediction.
- Development of comprehensive compound files is essential for robust modeling exercises.
Related Concept Videos
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...

